Hard to say for sure beyond the general recovery in biotechs, but there have been some favourable analyst opinions in financial media recently.
Ann: Successful OrthoATI clinical trial, page-34
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
-0.005(1.33%) |
Mkt cap ! $77.45M | |||
| Open | High | Low | Value | Volume |
| 36.8¢ | 37.0¢ | 36.5¢ | $9.674K | 26.23K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 28876 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2024 (20 minute delay) ? |
| OCC (ASX) Chart |